Our Pricing

How Cold Sore Treatment Works: Complete Guide

Published on: June 03, 2026

Understanding how cold sore treatment works UK helps you choose the most effective option for rapid symptom relief. At Cured Pharmacy, we dispense genuine aciclovir-based treatments that target the herpes simplex virus at cellular level, reducing outbreak duration when applied early [1].

How Aciclovir Works Against Cold Sores

Aciclovir is a nucleoside analogue antiviral medication that specifically targets the herpes simplex virus type 1 (HSV-1), the primary cause of cold sores [1]. Once applied topically, aciclovir penetrates infected skin cells where it undergoes phosphorylation by viral thymidine kinase, converting it into its active triphosphate form.

This active form selectively inhibits viral DNA polymerase, preventing the virus from replicating its genetic material [1]. Because human cells lack the viral enzyme required for activation, aciclovir demonstrates exceptional selectivity — it targets infected cells whilst leaving healthy tissue largely unaffected. Clinical trials show that when applied at the first sign of tingling (prodromal stage), aciclovir can reduce healing time by an average of 0.5 to 1 day compared to placebo [2].

The key to effectiveness lies in early application. The herpes simplex virus replicates most rapidly during the first 48 hours after symptoms begin, so initiating treatment during the tingling or redness stage yields better outcomes than waiting until blisters fully develop [2].

Aciclovir Cold Sore Treatment: Cream vs Tablets

Aciclovir is available in two primary formulations for cold sore management: topical cream (5% concentration) and oral tablets (typically 200mg or 400mg doses). Each has distinct advantages depending on outbreak severity and patient circumstances.

Topical aciclovir cream works locally at the site of infection and is ideal for mild to moderate outbreaks. The 5% cream formulation delivers high concentrations directly to affected tissue with minimal systemic absorption, reducing the risk of side effects [3]. Most patients apply the cream five times daily for four to five days, beginning at the first sign of symptoms.

Oral aciclovir tablets provide systemic antiviral coverage and are typically reserved for severe or frequent outbreaks (more than six episodes annually). Oral treatment achieves higher blood concentrations of the active drug, which may be beneficial for immunocompromised patients or those with particularly aggressive infections [3]. However, oral aciclovir requires a prescription from a UK prescriber following clinical assessment.

Which Formulation Is Right for You?

For most people experiencing occasional cold sores, topical aciclovir cream offers convenient, effective treatment without the need for systemic medication. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), recommends starting with topical treatment for first-line management, escalating to oral therapy only if outbreaks become frequent or severe enough to warrant systemic intervention.

How Cold Sore Treatment Works: The Viral Replication Cycle

To understand why timing matters so critically in cold sore treatment, it helps to understand the HSV-1 replication cycle. After initial infection (often during childhood), the herpes simplex virus remains dormant in nerve ganglia near the base of the skull. Reactivation occurs when triggers such as stress, illness, UV exposure, or immune suppression prompt the virus to travel down nerve fibres to the skin surface [4].

Once the virus reaches epithelial cells, it begins rapid replication — a single infected cell can produce thousands of viral particles within hours. This exponential replication causes the characteristic progression from tingling to redness, then fluid-filled blisters, and finally crusting. Each stage represents a different phase of viral activity.

Antiviral treatments like aciclovir are most effective during early replication phases. By the time blisters have fully formed, much of the viral replication has already occurred, which explains why late application yields more modest benefits [4]. This is why UK clinical guidelines emphasise starting treatment at the prodromal stage — the tingling or burning sensation that precedes visible lesions.

Recognising Early Warning Signs

Most people who experience recurrent cold sores learn to recognise their personal warning signs: tingling, itching, burning, or tightness around the lips or nose. Applying aciclovir cream within one hour of noticing these symptoms maximises treatment effectiveness and may prevent blister formation entirely in some cases.

Clinical Evidence: How Effective Is Cold Sore Treatment?

Multiple randomised controlled trials have evaluated topical aciclovir's effectiveness for recurrent herpes labialis. A meta-analysis of 21 clinical trials involving over 9,000 patients found that topical aciclovir reduced mean healing time by approximately 0.5 days compared to placebo when applied five times daily [2].

Whilst this reduction may seem modest, patient-reported outcomes show meaningful improvements in pain, discomfort, and quality of life. Early treatment (within 1 hour of symptom onset) produced better results than delayed application, with some studies showing up to 1-day reduction in healing time and decreased lesion severity [2][5].

Oral aciclovir demonstrates greater efficacy for severe outbreaks. Clinical trials using 400mg five times daily for five days showed healing time reductions of 1 to 2 days compared to placebo, with significant decreases in pain scores and viral shedding duration [5]. However, the systemic route carries a higher side effect burden, including potential gastrointestinal upset and headache.

Proper Application Technique for Maximum Effectiveness

Correct application technique significantly influences treatment outcomes. Before applying aciclovir cream, wash your hands thoroughly and gently clean the affected area with mild soap and water. Pat dry with a clean towel — avoid rubbing, which can spread the virus to adjacent skin.

Apply a thin layer of cream to cover the entire cold sore and approximately 5mm of surrounding skin. The cream should be massaged in gently until no longer visible. Most formulations recommend application five times daily at approximately four-hour intervals, continuing for four to five days or until the lesion has healed [1].

Wash your hands immediately after application to prevent viral transmission to other body sites or individuals. Avoid touching or picking at the cold sore, and never share towels, utensils, or lip products during an active outbreak. These hygiene measures complement antiviral treatment and reduce transmission risk.

Common Application Mistakes to Avoid

Many patients apply too little cream or fail to extend coverage beyond the visible lesion margin. HSV-1 often infects cells surrounding the obvious blister, so inadequate coverage allows continued viral replication. Similarly, inconsistent dosing (missing applications) reduces drug concentrations below therapeutic levels, diminishing effectiveness.

When to Seek Additional Medical Advice

Most cold sores resolve within 7 to 10 days with or without treatment. However, certain circumstances warrant consultation with a healthcare professional. Seek medical advice if your cold sore has not healed after 10 days of treatment, as this may indicate secondary bacterial infection or an underlying immune issue requiring systemic therapy.

Patients with compromised immune systems (due to HIV, chemotherapy, or immunosuppressive medications) should always consult a prescriber before treating cold sores, as they may require oral antiviral therapy from the outset. Similarly, cold sores affecting the eyes require urgent medical attention — ocular herpes can cause serious complications including vision loss if untreated [4].

Frequent outbreaks (six or more per year) may benefit from suppressive therapy, where low-dose oral aciclovir is taken daily to prevent recurrences. This approach has shown up to 80% reduction in outbreak frequency in clinical trials [5]. Our UK-registered clinical team can assess your suitability for suppressive therapy through a free online consultation.

Scientific References

1. Spruance, S. L., et al. (2002). Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. Journal of Infectious Diseases, 185(9), 1295-1302. https://doi.org/10.1086/340043 [accessed 13 August 2026]
2. Chi, C. C., et al. (2015). Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database of Systematic Reviews, 2015(8), CD010095. https://doi.org/10.1002/14651858.CD010095.pub2 [accessed 13 August 2026]
3. Spruance, S. L., et al. (1997). Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrobial Agents and Chemotherapy, 41(7), 1367-1372. https://doi.org/10.1128/AAC.41.7.1367 [accessed 13 August 2026]
4. Arduino, P. G., & Porter, S. R. (2008). Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features. Journal of Oral Pathology & Medicine, 37(2), 107-121. https://doi.org/10.1111/j.1600-0714.2007.00586.x [accessed 13 August 2026]
5. Rooney, J. F., et al. (1993). Oral acyclovir to suppress frequently recurring herpes labialis. A double-blind, placebo-controlled trial. Annals of Internal Medicine, 118(4), 268-272. https://doi.org/10.7326/0003-4819-118-4-199302150-00004 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.